Cited by 168Liver Diseases and ImmunityGut microbiota and healthDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis

Chen, Weihua, Wei, Yiran, Xiong, Aizhen, Li, Yanmei, Guan, Huida, Wang, Qixia, Miao, Qi, Bian, Zhaolian, Xiao, Xiao, Lian, Min, Zhang, Jun, Li, Bo, Cao, Qin, Fan, Zhuping, Zhang, Weici, Qiu, Dekai, Fang, Jingyuan, Gershwin, M. Eric, Yang, Li, Tang, Ruqi, Ma, Xiong·2020·Clinical Reviews in Allergy & Immunology

DOI 10.1007/s12016-019-08731-2

Open this paper in CoChat — free account

Abstract

Accumulation of bile acids (BAs) contributes significantly to the pathogenesis of primary biliary cholangitis (PBC). Here, we sought to systematically characterize the serum and fecal BA profiles and the linkage between BAs and gut microbiota in PBC. The serum and fecal BAs were compared between 65 UDCA treatment-naive PBC and 109 healthy controls using UPLC-MS in cross-sectional study. In a prospective study, a subgroup of patients was enrolled for BA and microbiota analysis before and after UDCA therapy. BA compositions in serum and feces significantly differed between treatment-naive PBC and controls. Particularly, PBC was associated with decreased conversions of conjugated to unconjugated, and primary to secondary BAs, indicating impaired microbial metabolism of BAs. PBC patients at advanced stage exhibited a more abnormal BA profile compared with early-stage patients. UDCA treatment led to a decreased level of taurine-conjugated BAs, thereby reversing the conjugated/unconjugated ratio in PBC. Moreover, the level of secondary BAs such as DCA and conjugated DCA inversely correlated with PBC-enriched gut microbes (e.g., Veillonella, Klebsiella), while positively correlated with control-enriched microbes (e.g., Faecalibacterium, Oscillospira). Microbiota analysis also revealed a significant increase of taurine-metabolizing bacteria Bilophila spp. in patients after UDCA, which was strongly correlated with decreased taurine-conjugated BAs. In addition, serum FGF19 was remarkably increased in treatment-naïve PBC and decreased after UDCA. Our study established specific alterations of BA compositions in serum and feces of PBC, suggesting the potential for using BAs for diagnosis, and highlighting the possibility of modulating BA profile by altering gut microbiota. Graphical Abstract.

Integrity signals

Registry

Crossref · 10.1007/s12016-019-08731-2

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlstrom, A. M., Sayin, S. I., Marschall, H., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,969
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Primary Biliary Cirrhosis
Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509840 · Cited by 1,131
Primary biliary cirrhosis # †
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099

Flagged first, then by citations

Show all 52 references

Sorted by citations

Items 101–168 of 168

Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
Zhao, J., Yue, P., Mi, N., Li, M., Fu, W., Zhang, X., Gao, L., Bai, M., Tian, L., Jiang, N., et al. (2024) · Medical Review · doi:10.1515/mr-2024-0029 · Cited by 7
Self-citation
Intestinal microbiota in biliary diseases
Xia, Q., Liu, Q., & Ma, X. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000910 · Cited by 8
Self-citation
Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease
Basuni, A. A., Sweed, D., Elgazzar, M. F., & Khalil, A. A. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00378-9 · Cited by 7
Characteristics of intestinal flora in nonobese nonalcoholic fatty liver disease patients and the impact of ursodeoxycholic acid treatment on these features
Wang, L., Xu, J., You, N., Shao, L., Zhuang, Z., Zhuo, L., Liu, J., & Shi, J. (2024) · Lipids · doi:10.1002/lipd.12410 · Cited by 6
Profiles of biliary microbiota in biliary obstruction patients with Clonorchis sinensis infection
Chen, R., Li, X., Ding, J., Wan, J., Zhang, X., Jiang, X., Duan, S., Hu, X., Gao, Y., Sun, B., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1281745 · Cited by 5
Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway?
Abenavoli, L., Scarlata, G. G. M., Scarpellini, E., Procopio, A. C., Ponziani, F. R., Boccuto, L., Ćetković, N. B., & Luzza, F. (2024) · Minerva Gastroenterology · doi:10.23736/s2724-5985.23.03590-8 · Cited by 5
Conjugated bile acids in serum reflect disease severity and predict survival in chronic liver disease of humans and rats
Eguchi, A., Iwasa, M., Miyazaki, T., Tempaku, M., Ichishi, M., Tamai, Y., Shigefuku, R., Kobayashi, Y., Honda, A., Watanabe, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-17560-7 · Cited by 4
Soluble Herpes Virus Entry Mediator and Type II/III Interferons Are Upregulated in Primary Biliary Cholangitis
Chung, Y., Tsou, H. L. P., Heneghan, M. A., Chokshi, S., & Riva, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020605 · Cited by 4
Risk of colon polyps and colorectal cancer in primary biliary cholangitis, a population-based retrospective cohort study in Taiwan
Chen, P.-T., Chien, W.-C., Chung, C., Chen, P., Huang, T., & Chen, H. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.04.007 · Cited by 4
Gut Microbiota: Implications in Pathogenesis and Potential Therapeutic Target in Primary Biliary Cholangitis
Nie, Y., Shi, Y., & Yang, Y. (2025) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2025.00212 · Cited by 3
Melatonin alleviates cholestatic liver injury through modulating gut microbiota and activating the NRF2/HO-1 antioxidant pathway
Dong, S., Liu, J., Xuan, C., Zhou, S., Han, Z., Zhu, C., Chen, N., Liu, R., Wang, W., Chu, H., et al. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103131 · Cited by 3
Bile Acid Metabolites Control Th17/Treg Balance in Primary Biliary Cholangitis: Mechanisms of Disease Progression and Therapeutic Targets
Liu, Z., Jiang, H., Li, F., Xie, R., & Wang, H. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70189 · Cited by 3
Research advances on whole grains benefit on metabolic syndrome via gut homeostasis regulation
Wang, X., Liang, H., Zhu, H., Wang, Y., Sun, H., Liu, L., Xiao, J., Yan, N., Wang, C., & Liu, L. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2599514 · Cited by 3
Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review
Papachristou, K., Angelara, M., Manganas, K., & Ανδρουτσάκος, Θ. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031388 · Cited by 3
Anthocyanins from Lycium ruthenicum Murray Prevent High-Fat Diet-Induced Obesity in Female Mice via Gut Microbiota-Related Bile Acids Metabolism
Li, H., Zhang, M., Tan, T., Li, S., Mi, J., Lu, L., Yan, Y., & Ran, L. (2024) · Natural Product Communications · doi:10.1177/1934578x241246678 · Cited by 3
Pathophysiology of biochemical signs of primary biliary cholangitis
Reshetnyak, V. I., & Maev, I. V. (2023) · Exploration of Digestive Diseases · doi:10.37349/edd.2023.00024 · Cited by 3
Homogeneity Gut microbiome Characteristics in Autoimmune Epithelitis: Primary Biliary Cholangitis and Primary Sjögren’s Syndrome.
Liu, B. (2024) · Journal of Immunology · doi:10.52338/immunology.2024.3917 · Cited by 3
Multi-omics analysis reveals gut microbiota-metabolite interactions and their association with liver function in autoimmune overlap syndrome
Wang, Q., Sun, L., Shi, H., Ma, X., Gao, W., Xu, B., Xiao, L., Liu, Y., Huang, C., & Jin, R. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i25.106371 · Cited by 3
Self-citation
Attenuation of the severity and changes in the microbiota in an animal model of primary biliary cholangitis by FOXP3− regulatory T cells
Chen, Y., Chen, S., Chuang, Y., & Chiang, B. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.187 · Cited by 3
The inflammation-aging axis: Shared and distinct mechanisms in physiological gut aging and IBD-associated accelerated gut aging
Yang, L., Jiang, Z., Sun, Q., Karako, K., Yuan, L., & Song, P. (2025) · BioScience Trends · doi:10.5582/bst.2025.01279 · Cited by 2
Self-citation
Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor β1/SMAD Signaling
Park, K., Kim, J. Y., Roh, S. W., Savaliya, B., Turner, C. A., Pirius, N., LaRusso, N. F., Song, K., & O’Hara, S. P. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101789 · Cited by 2
Tumor necrosis factor alpha-induced protein 3: A key biomarker for response to ursodeoxycholic acid in primary biliary cholangitis
Zang, B., Li, J., Liu, Q.-X., Yao, Y., Li, H., Wang, Y., Wang, J., Yang, Y., Liang, R., Xin, X.-R., et al. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.107666 · Cited by 2
The Pathogenesis of Autoimmune Liver Diseases
Kovalic, A. J., & Bonkovsky, H. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-33628-8_2 · Cited by 2
Pediatric Autoimmune or Primary Sclerosing Cholangitis: Metronidazole Effectiveness on Biochemical Data, Bile Acid Profile, and Gut Microbiota: A Pilot Study
Karemera, M., Verce, M., Roumain, M., Muccioli, G. G., Cani, P. D., Everard, A., Stéphenne, X., & Sokal, E. M. (2023) · JPGN Reports · doi:10.1097/pg9.0000000000000334 · Cited by 2
Bile acids in rainbow trout : Keeping a balance
Staessen, T. W. O. (2021) · doi:10.18174/534506 · Cited by 2
The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
Divya, K. P., Hari, P., Kanwar, N., Aggarwal, N., Dhoat, P. S., Liu, L., Kanwal, A., & Singh, S. P. (2023) · Advanced Gut & Microbiome Research · doi:10.1155/2023/5431615 · Cited by 1
Yixintai treats chronic heart failure in rats by regulating gut microbiota and bile acid
Shi, M., Hui, Y., Liu, C., Wei, J., Wang, Z., Huang, A., Zeng, Q., Li, Y., & Guo, Z. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1672313 · Cited by 1
Self-citation
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives
Romeo, M., Nardo, F. D., Basile, C., Napolitano, C., Vaia, P., Martinelli, G., Gregorio, A. D., Puorto, L. D., Indipendente, M., Dallio, M., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120597 · Cited by 2
The gut-liver/bile axis: Gut microbiota and bacterial extracellular vesicles remodeling hepatobiliary pathogenesis
Hu, S., He, C., Sun, K., Zhou, H., Liu, X., Wang, D. H., Li, S., Yu, H., Xu, K., & Li, W. (2026) · iScience · doi:10.1016/j.isci.2026.115623 · Cited by 1
Profiling bile acid composition in bile from mice of different ages and sexes
Liu, J., Zhao, Q. C., Qu, C., Ge, K., Yang, L., Jia, W. P., & Zhao, A. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1626215 · Cited by 1
Self-citation
Gender and Age Differences in the Hepatic Consequences of “Humanized” Bile Acid Compositions in Mice
Zhao, X. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.005
Effect of Periampullary Diverticulum on Biliary Flora and the Formation of Common Bile Duct StonePreprint
Hou, S., Wang, H., Zhang, L., Yu, T., & Qiao, Z. (2020) · Research Square · doi:10.21203/rs.3.rs-75499/v1
Terapias usuales y emergentes en colangitis biliar primaria
Díaz-Duque, J. C., Palacio-Valencia, V., Suárez-Meneses, J., Montaña-López, J. A., & Palacio-Sánchez, E. (2022) · Hepatología · doi:10.52784/27112330.156
Modulación de la microbiota intestinal en el tratamiento de la enfermedad de hígado graso no alcohólico y síndrome metabólico. Estudio de un tratamiento experimental con quercetina y de la transferencia de microbiota a ratones libres de gérmenes = Intestinal microbiota modulation in the treatment of non-alcoholic fatty liver disease and metabolic syndrome. Study of an experimental treatment with quercetin and intestinal microbiota transfer to germ-free mice
Porras, D. (2021) · Buleria (Universidad de León) · doi:10.18002/10612/13641
Microorganisms in the Pathogenesis and Management of Primary Biliary Cholangitis (with Focus on SARS-CoV-2 & Gut Microbiota)
Cozma, M.-A., & Diaconu, C. C. (2022) · Springer eBooks · doi:10.1007/978-981-19-1946-6_7
Bile acid signalling in type 2 diabetes and its co-morbidities
Palmiotti, A. (2023) · doi:10.33612/diss.797737443
Clinical features in primary biliary cholangitis:A retrospective analysis of 67 casesPreprint
Zhou, J., Li, S., Chen, M., Zhou, F., Liu, J., Chen, L., & Ren, J. (2024) · Research Square · doi:10.21203/rs.3.rs-3975134/v1
An untargeted comparative metabolomics analysis of infants with and without late-onset breast milk jaundice
Cui, M., Guo, Q., Zhao, S., Liu, X., Yang, C., Liu, P., & Wang, L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308710
Potential Role of Bile Acids in the Pathogenesis and Treatment of PBC
Lu, Y., Wang, D., & Song, L. (2025) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2025.07(02).19
Liver immunology: Biological role and clinical significance
Kotlyarov, S. N. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.107541 · Cited by 1
Insights into the association between primary biliary cholangitis and colorectal neoplasia: More details, more significance
Zou, M., Yang, Z., Gao, F., & Yang, Z. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.08.024
The adhesion molecules β7 integrin and L-selectin contribute to cholestatic liver disease in male micePreprint
Seeger, A., Babbar, A., Eswaran, S., Adams, M., Muschaweck, M., Treichel, N. S., Clavel, T., Yin, G., Guillot, A., Scheuer, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.24.678237
Bioengineered 3D hPSC-cholangiocyte ducts with physiological signals for biliary disease modellingPreprint
Tian, B., Ogawa, M., Kondo, M., Langeveld, G., Huan, L., Zhang, F., Hollinger, A., Deir, S., Bear, C. E., Zhang, B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.10.686855
Schisandra chinensis Bee Pollen Extract Alleviates Obesity by Modulating Gut Microbiota-Driven Bile Acid Metabolism
An, X., Zhang, J., Chou, R., Zhao, C., Zhao, H., Cao, W., & Cheng, N. (2025) · Nutrients · doi:10.3390/nu17223597
Self-citation
Additional file 2 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734485
Additional file 7 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734500
Additional file 10 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734509
Additional file 1 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734482
Additional file 13 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734518
Additional file 14 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734521
Additional file 6 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734497
Additional file 5 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734494
Additional file 4 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734491
Additional file 8 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734503
Additional file 9 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734506
Additional file 12 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734515
Additional file 3 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734488
Additional file 11 of Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, W., Song, T., Huang, Z., Liu, Y., Xu, B., & Huang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26734512
Endoscopic Findings for Patients with Primary Biliary Cholangitis: A Single-Center Experience
Chen, H.-W., Chen, P.-T., & Liang, Y.-J. (2026) · Gastroenterology Insights · doi:10.3390/gastroent17010004
Longitudinal multi-omics pilot study: Small sample size human model of gut microbiota-mitochondrial metabolic dysregulation in primary biliary cholangitis
Lou, J., Hu, X., Yan, R., Duan, J., Du, B., Wang, F., Shao, Y., Jiang, H., Li, L., & Lv, L. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128465
First documented case of Siphonobacter curvatus bloodstream infection in an elderly patient with biliary abnormalities and suspected immune dysregulation
Zhang, P., Chen, L., Gu, J., Mao, L., & Shi, J. (2026) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2026.117372
Microbiome-immune interactions in autoimmune liver diseases
Kiseleva, Y. V., Maslennikov, R. V., Poluektova, E. A., Zolnikova, O., Sigidaev, A. S., Zharikov, Y. O., Shirokova, E. N., & Ivashkin, V. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i12.115853 · Cited by 1
Therapeutic modulation of the gut microbiota by traditional Chinese medicine in the management of cholestatic liver injury
Ding, X., Wang, J., Wang, Y., Xu, H., & Liu, Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1807162 · Cited by 1
The Dual Roles of Gut Microbiota in Biliary Atresia: Mechanisms, Biomarker Potential, and Therapeutic Implications
Yan, J., Jiang, L., Li, Y., Lv, H., Wu, W., Yang, L., Chen, J., & Ding, S. (2026) · Microorganisms · doi:10.3390/microorganisms14051076
Self-citation
Multiomics and Cohort Validation Identified the Metabolic Link Between Hashimoto′s Thyroiditis and Primary Biliary Cholangitis
Hu, Y., Zhang, H., Zhao, H., Men, X., Cui, L., Guo, C., Wang, J., Liu, Y., Shang, Y., & Han, Y. (2026) · Human Mutation · doi:10.1155/humu/3956260
Clinical Relevance of Bile Acid and Bile Acid-Related Therapy in Liver Cirrhosis: A Review
Cao, G., Zhao, H., Lin, G., Chen, J., Gao, C., Méndez‐Sánchez, N., Gao, F., & Qi, X. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03696-z
Gut Commensal Bacteria Ameliorate Liver Fibrosis by Inhibiting Macrophage M1 Polarization Through Secondary Bile Acids in a Murine Liver Fibrosis Model
Xiang, H., Xiang, H., Liu, Z., Chen, H., Luo, Z., Guo, S., & Zhang, J. (2026) · Microorganisms · doi:10.3390/microorganisms14092035
Self-citation
From dietary exposure to organ injury: microbiome-mediated biotransformation of food-chain xenobiotics across the gut–liver–kidney axis
Li, G., Xiong, Y., Yu, X., Yu, J., & Xu, R. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1977638

Authors: Chen, W., Wei, Y., Xiong, A., Li, Y., Guan, H., Wang, Q., Miao, Q., Bian, Z., Xiao, X., Lian, M., Zhang, J., Li, B., Cao, Q., Fan, Z., Zhang, W., Qiu, D., Fang, J., Gershwin, M. E., Yang, L., Tang, R., & Ma, X.
Affiliations: Shanghai Jiao Tong University (CN)
Shanghai University of Traditional Chinese Medicine (CN)
Nantong University (CN)
University of California, Davis (US)
Corresponding author: Yang, Li
Tang, Ruqi
Ma, Xiong
ORCID: Wei, Yiran
Xiong, Aizhen
Li, Yanmei
Guan, Huida
Wang, Qixia
Bian, Zhaolian
Xiao, Xiao
Lian, Min
Zhang, Jun
Li, Bo
Zhang, Weici
Gershwin, M. Eric
Yang, Li
Tang, Ruqi
Ma, Xiong
Venue: Clinical Reviews in Allergy & Immunology
Publisher: Springer Science and Business Media LLC
Published: 2019-03-21
Volume: 58
Issue: 1
Pages: 25-38
ISSN: 1080-0549 (ISSN-L)
1559-0267
DOI: 10.1007/s12016-019-08731-2
OpenAlex: W2924978408
Cited by: 166
References: 52
Citations by year: 2026: 15 · 2025: 26 · 2024: 36 · 2023: 24 · 2022: 21 · 2021: 32 · 2020: 9 · 2019: 3
FWCI: 10.45
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Clinical Reviews in Allergy & Immunology (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (81620108002, 81771732, 81830016, 81570469, 81873561, 81573581, 81421001, 81500435)
Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant (20161311)
Topics: Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: primary biliary cirrhosis, bile acids, gut microbiota, fecal bile acids, taurine-conjugated bile acids, bile acid metabolism, FGF19, bile acid deconjugation, secondary bile acids, Bilophila, Veillonella, Klebsiella, Faecalibacterium, Oscillospira, disease severity
MeSH terms: Gastrointestinal Microbiome, Adult, Aged, Bile Acids and Salts, Cross-Sectional Studies, Disease Susceptibility, Feces, Female, Fibroblast Growth Factors, Humans, Liver Cirrhosis, Biliary, Liver Function Tests, Male, Middle Aged, Models, Biological, Severity of Illness Index, Biomarkers, Cluster Analysis, Case-Control Studies, Computational Biology, Metagenome, Metagenomics, Hydrophobic and Hydrophilic Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks